SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,629,000 | -50.5% | 206,054 | -45.6% | 0.03% | -42.6% |
| Q4 2021 | $23,490,000 | +4.6% | 379,007 | +7.1% | 0.05% | 0.0% |
| Q3 2021 | $22,453,000 | +499.5% | 353,916 | +678.7% | 0.05% | +500.0% |
| Q2 2021 | $3,745,000 | +22.9% | 45,448 | +8.1% | 0.01% | +12.5% |
| Q4 2020 | $3,048,000 | – | 42,032 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |